Cargando…
Locoregional therapy in hepatocellular carcinoma: when to start and when to stop and when to revisit
With increasing therapeutic options available for advanced hepatocellular carcinoma (HCC), the timing and sequencing of locoregional and systemic therapy need to be re-examined. This is especially so for patients with intermediate HCC, so as to optimize responses while preserving liver reserves, and...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086015/ https://www.ncbi.nlm.nih.gov/pubmed/33887687 http://dx.doi.org/10.1016/j.esmoop.2021.100129 |